Expression of cell‐cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma
Authors:
- 1 March 2010
- journal article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 142 (3) , 332-337
Abstract
Objective: To evaluate the expression of cell‐cycle regulators in papillary thyroid carcinoma in relation to lymph node metastatic features, and to determine whether immunohistochemical staining of cell‐cycle markers can predict lymph node metastasis.Study Design: Cross‐sectional study of prior surgical specimens.Setting: Academic tertiary referral center.Subjects and Methods: We reviewed the clinical records of patients who had undergone surgery for thyroid cancer and follicular adenoma between January 2005 and May 2008 at our clinic. Among these cases, 92 patients, comprising 28 patients with follicular adenoma, 32 with papillary thyroid carcinoma without lymph node metastasis, and 32 with papillary thyroid carcinoma with lymph node metastasis, were selected randomly. Formalin‐fixed, paraffin‐embedded tissues from the 92 patients were immunohistochemically stained for cyclin D1, cyclin E, p27kip1, and p57kip2, and protein expression levels were quantified and compared among the groups.Results: Tumor specimens from the papillary thyroid carcinoma group had significantly higher expression levels of cyclin D1 and cyclin E, and cytoplasmic expression of p57kip2 than the other two groups (P < 0.05). In particular, all malignant cases expressed cyclin D1, and cytoplasmic p57kip2 was expressed only in malignant cases. Furthermore, differences in the grade of cyclin D1 expression according to lymph node metastasis were statistically significant (P < 0.05).Conclusion: Our results suggest that immunohistochemistry of certain cell‐cycle regulators may be helpful in the diagnosis of papillary thyroid carcinoma, and that cyclin D1 in particular may be a useful marker for evaluating lymph node metastasis.Keywords
This publication has 19 references indexed in Scilit:
- Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotypeHuman Pathology, 2007
- Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progressionSurgery, 2006
- p57kip2expression is related to carcinogenesis and tumor progression in laryngeal tissuesActa Oto-Laryngologica, 2006
- Papillary Microcarcinomas of the Thyroid with Preoperatively Detectable Lymph Node Metastasis Show Significantly Higher Aggressive Characteristics on Immunohistochemical ExaminationOncology, 2005
- Altered Expression of Cyclins and Cell Cycle Inhibitors in Papillary Thyroid Cancer: Prognostic ImplicationsThyroid®, 2005
- Cyclin E expression in papillary thyroid carcinoma: Relation to stagingInternational Journal of Cancer, 2003
- Overexpression of Cyclin D1 and Underexpression of p27 Predict Lymph Node Metastases in Papillary Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2002
- Cancer Cell CyclesScience, 1996
- Treating Differentiated Thyroid Carcinoma: Where Do We Draw the Line?Mayo Clinic Proceedings, 1991
- G 1 Events and Regulation of Cell ProliferationScience, 1989